New York Study Aims to Assess Utility of Clinical Whole-Genome Sequencing Across Diseases NEW YORK – A clinical research study recently launched by researchers at Weill Cornell Medicine, New York Presbyterian, and the New York Genome Center, with ...
Read more Weill Cornell Medicine, NewYork-Presbyterian Hospital and Illumina Collaborate on Scalable Clinical Whole-Genome Sequencing Initiative Associated Collaboration with the New York Genome Center to Expand Patient Access to Advanced Genomic...
Read more
Consortium to Bring Precision Medicine Approaches to Very Rare Cancers in NY Reprinted from GenomeWeb NEW YORK – When a patient turned up at the Weill Cornell Medical Center a few years ago with a typically benign kidney tumor type, it did not...
Read more